首页> 外文OA文献 >Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study

【2h】

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study

机译：obinutuzumab加上氟酰胺和环磷酰胺在先前未经处理的，适合慢性淋巴细胞白血病患者：绿色研究的亚组分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Francesc Bosch; Guy Cantin; Agostino Cortelezzi; Wolfgang Knauf; Mourad Tiab; Mehmet Turgut; Andrey Zaritskey; Jean-Louis Merot; Eugen Tausch; Kerstin Trunzer; Susan Robson; Ekaterina Gresko; Sebastian Böttcher; Robin Foà; Stephan Stilgenbauer; Véronique Leblond;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study [J] . Francesc Bosch, Guy Cantin, Agostino Cortelezzi, Leukemia . 2020,第2期

机译：obinutuzumab加上氟酰胺和环磷酰胺在先前未经处理的，适合慢性淋巴细胞白血病患者：绿色研究的亚组分析
2. Randomized Trial in Unfit, Elderly Chronic Lymphocytic Leukemia (CLL) Patients with Comorbidities of Dose-Reduced Oral Fludarabine and Cyclophosphamide Plus Obinutuzumab (FC plus G) Versus Chlorambucil Plus Obinutuzumab (Cbl plus G) As Front-Line Therapy [J] . Mulligan Stephen P., Freeman Jane A., Badoux Xavier, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：随机试验在不适合的老年慢性淋巴细胞白血病（CLL）患有剂量减少口服氟胺和环磷酰胺（Fc Plus G）的患者的患者，与氯镁加上obinutuzumab（CBL Plus G）作为前线疗法
3. Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997 [J] . Lucas David M., Ruppert Amy S., Lozanski Gerard, Leukemia and lymphoma . 2015,第11期

机译：细胞遗传学优先排序并包含分子标记可预测先前未接受氟达拉滨或氟达拉滨加环磷酰胺治疗的慢性淋巴细胞性白血病患者的治疗结果：一项美国III期人群间联合试验E2997的长期随访研究
4. Automatic detection of axillary lymphadenopathy on CT scans of untreated chronic lymphocytic leukemia patients [C] . Jiamin Liu, Jeremy Hua, Vivek Chellappa, Conference on computer-aided diagnosis . 2012

机译：在未经治疗的慢性淋巴细胞性白血病患者的CT扫描中自动检测腋窝淋巴结肿大
5. Risk Factors for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Incidence in Postmenopausal Women: A Women's Health Initiative (WHI) Study [D] . Maharry, Kati S. 2016

机译：绝经后妇女慢性淋巴细胞白血病和小淋巴细胞淋巴瘤发生率的危险因素：妇女健康倡议（WHI）研究
6. Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study [O] . Francesc Bosch, Guy Cantin, Agostino Cortelezzi, -1

机译：Obinutuzumab联合氟达拉滨和环磷酰胺治疗未经治疗的健康慢性淋巴细胞白血病患者：GREEN研究的亚组分析
7. PCN191 Cost-Effectiveness Analysis Of Obinutuzumab For Previously Untreated Chronic Lymphocytic Leukemia (Cll) In Portuguese Patients That Are Unsuitable For Full-Dose Fludarabine Based Therapy [O] . Paquete A, Miguel LS, Pereira C, 2015

机译：奥比努妥珠单抗治疗不适合全剂量氟达拉滨治疗的葡萄牙患者先前未经治疗的慢性淋巴细胞性白血病（Cll）的PCN191成本-效果分析

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study

著录项

引文网络

相似文献

相关主题

期刊订阅